BioSpace News Archive

Relmada Therapeutics, Inc. today announced that Sergio Traversa , Chief Executive Officer, Maged Shenouda , Chief Financial Officer, and Cedric O’Gorman, Chief Medical Officer, will participate in the Goldman Sachs Global Healthcare Conference in one-on-one investor meetings and a fireside chat on Wednesday, June 14, 2023, at 3:20pm PT / 6:20pm ET in Dana Point, CA.

Perrigo Company plc, a leading provider of Consumer Self-Care Products, announced the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.

Vera Therapeutics, Inc. today announced that the Company’s management team will participate in the 44th Annual Goldman Sachs Global Healthcare Conference, which is taking place in Dana Point, CA from June 12 – 15, 2023.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic conferences, including the European Hematology Association (EHA) 2023 Congress, the European Human Genetics (ESHG) 2023 Conference and the European Association for Cancer Research (EACR) 2023 Congress.

Candel Therapeutics, Inc. today announced the appointment of Nicoletta Loggia, PhD, RPh, to the Company’s Board of Directors (Board) effective June 7, 2023.

Hememics Biotechnologies, Inc. has entered into a strategic partnership with General Graphene Corporation of Knoxville Tennessee, the culmination of a four-year collaborative effort to develop a scalable, non-clean-room process for the manufacturing of the company’s 32-plex, graphene biosensor chips.

CorNeat Vision’s EverPatch, a synthetic tissue substitute, has been granted 510(k) clearance by the US Food & Drug Administration (FDA).

Avidity Biosciences, Inc. (Nasdaq: RNA) today announced that the company will be presenting two oral presentations and two poster presentations at the 30th Annual FSHD Society International Research Congress, being held June 15-16, 2023, in Milan, Italy.

Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) (“Justera” or the “Company”) is pleased to announce that the Company has secured two new bricks and mortar retail locations in Vancouver.

GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead